Global Oncology Transition Director
Global Oncology Transition Director
Location Cambridge UK
At AstraZeneca we work together across global boundaries to make an impact and find answers to challenges. We do this with the upmost integrity even in the most difficult situations because we are committed to doing the right thing. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people's exceptional skills with those of people from all over the globe.
As a Global Oncology Transition Director in Cambridge working within the Global Medicines Development (GMD) Department, you'll play a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients' lives.
In Global Medicines Development (GMD) we have a crucial role to play. Faced with complex disease challenges, we're focused on exceptional performance to drive the best and most transformative drug programmes ever. To achieve that, we need talented, committed people across our functions. We're making a significant investment in helping them reach their full potential, building the extensive drug leadership capabilities and experience that could make a difference to millions of patients.
AstraZeneca's vision in Oncology is to help patients by redefining the cancer-treatment paradigm, with the aim of bringing six new cancer medicines to patients between 2013 and 2020. A broad pipeline of next-generation medicines is focused principally on four disease areas - breast, ovarian, lung and haematological cancers. As well as other tumour types, these are being targeted through four key platforms - immunotherapy, the genetic drivers of cancer and resistance, DNA damage repair, and antibody drug conjugates, underpinned by personalised healthcare and biomarker technologies.
Main Duties and Responsibilities
As the Global Oncology Transition Director, you will work alongside the IPT leader to deliver a fast and comprehensive PoC study that supports a clear line of sight to first approval as well as a differentiating, regulatory robust and competitive phase III development programmes building from those studies. To do this you will utilize your extensive expertise in later stage oncology development and oncological science to identify highly differentiated development and PoC options.
You will be required to work collaboratively in a globally matrixed environment to bring together translation of science, dosing and early clinical evidence and late stage development knowledge, ensuring lock-step with the respective IPT lead.
Overall in this role, you will support the IMED teams to deliver more and higher quality successful Phase III transitions by championing best execution together, independent of function. You will ensure there is a stronger line of sight to competitive/regulatory position and enterprise demands, securing the best plan for the asset and AstraZeneca. By adopting a 'look forward' operational strategy.
This is a new role in the GMD team and as such is an exciting opportunity for you to drive it and make a real difference in how late stage research and early stage trials align to ensure the best outcomes.
- Advanced degree in science-related field, such as Medicine, Pharmacy, Pharmacology, or equivalent.
- Deep knowledge on oncology drug development and data generation models.
- Strong interpersonal and project management skills.
- Extensive experience managing programs in a global team environment.
- Strong knowledge of medical strategy, clinical development, and medical science liaison areas.
- Ability to work effectively in a cross-functional team environment.
- Doctorate in Medicine, Pharmacy, Pharmacology, or equivalent.
- Existing peer-level ESE relationships.
- Expert oncology clinical knowledge.
- Substantial experience in a strategy-setting role within a core medical team.
- Global experience within the pharmaceutical industry, preferably across multiple commercial and development roles.
- Working knowledge of FDA and EMA requirements.
Next Steps - Apply today!
To be considered for this exciting opportunity, please complete the full application on our website at your earliest convenience - it is the only way that our Recruiter and Hiring Manager can know that you feel well qualified for this opportunity. If you know someone who would be a great fit, please share this posting with them.
The closing date for this application is the 3rd September 2017
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law.